CVS Health (CVS) reported $94.59 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 7%. EPS of $2.25 for the same period compares to $1.31 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $92.95 billion, representing a surprise of +1.76%. The company delivered an EPS surprise of +31.58%, with the consensus EPS estimate being $1.71.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how CVS Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Medical benefit ratio (MBR): 87.3% compared to the 88.6% average estimate based on seven analysts.
- Medical membership - Total: 27.08 million compared to the 25.99 million average estimate based on five analysts.
- Medical membership - Insured - Medicare Supplement: $1.25 billion compared to the $1.26 billion average estimate based on four analysts.
- Pharmacy claims processed: 464.2 million versus the four-analyst average estimate of 467.42 million.
- Revenue- Health Care Benefits: $34.81 billion versus the six-analyst average estimate of $33.66 billion. The reported number represents a year-over-year change of +8%.
- Revenue- Pharmacy & Consumer Wellness Segment: $31.91 billion versus the six-analyst average estimate of $31.20 billion. The reported number represents a year-over-year change of +11.1%.
- Net revenue- Health Services segment: $40.12 billion versus $43.36 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -0.4% change.
- Revenue- Corporate/Other: $133 million versus the four-analyst average estimate of $117.14 million.
- Revenue- Pharmacy & Consumer Wellness Segment- Pharmacy: $26.08 billion compared to the $25.29 billion average estimate based on four analysts. The reported number represents a change of +14.5% year over year.
- Revenue- Pharmacy & Consumer Wellness Segment- Front store: $5.24 billion compared to the $5.43 billion average estimate based on four analysts. The reported number represents a change of -2.4% year over year.
- Revenue- Health Care Benefits Segment- Net investment income: $387 million versus $297.44 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +9.6% change.
- Revenue- Health Care Benefits Segment- Services: $1.62 billion versus $1.60 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +7.4% change.
View all Key Company Metrics for CVS Health here>>>
Shares of CVS Health have returned -2% over the past month versus the Zacks S&P 500 composite's -0.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CVS Health Corporation (CVS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
